What does this research mean for the field?

Advances in multi-omics research and molecular subtyping are driving the development of precision therapies for bladder cancer, though significant challenges such as tumor heterogeneity and therapy resistance remain. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

December 8, 2025Frontiers in Oncology6 citationsOpen Access

Molecular mechanisms and translational advances in bladder cancer: from driver genes to precision therapy

View Full Paper

Ask AI

Bookmark

Authors

JXJinjie Xiang LYLuo Yuhui BZBaiyu Zhang

Discussion

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Xiang et al. (2025) studied this question.

synapsesocial.com/papers/6a5dbc651eb962e53e89e1ea https://doi.org/10.3389/fonc.2025.1670574

View Full Paper

Ask AI

Bookmark

December 8, 2025Frontiers in Oncology6 citationsOpen Access

Molecular mechanisms and translational advances in bladder cancer: from driver genes to precision therapy

View Full Paper

Ask AI

Bookmark

Authors

JXJinjie Xiang LYLuo Yuhui BZBaiyu Zhang

Discussion

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Xiang et al. (2025) studied this question.

synapsesocial.com/papers/6a5dbc651eb962e53e89e1ea https://doi.org/10.3389/fonc.2025.1670574

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark